The Enterprise Value as of September 2024 (TTM) for Celldex Therapeutics, Inc. (CLDX) is 2.73B

According to Celldex Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.73B. This represents a change of 33.59% compared to the average of 2.05B of the last 4 quarters.

Celldex Therapeutics, Inc. (CLDX) Historical Enterprise Value (quarterly & annually)

How has CLDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Celldex Therapeutics, Inc. over the last ten years is 979.77M. The current 2.73B Enterprise Value has changed 27.80% with respect to the historical average. Over the past ten years (40 quarters), CLDX's Enterprise Value was at its highest in in the June 2024 quarter at 2.53B. The Enterprise Value was at its lowest in in the March 2020 quarter at 9.96M.

Celldex Therapeutics, Inc. (CLDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Celldex Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celldex Therapeutics, Inc. (CLDX) Average Enterprise Value

How has CLDX Enterprise Value performed in the past?

The current Enterprise Value of Celldex Therapeutics, Inc. (CLDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Celldex Therapeutics, Inc. (CLDX) Enterprise Value vs. Peers

How is CLDX’s Enterprise Value compared to its peers?

Celldex Therapeutics, Inc.’s Enterprise Value is less than IDEAYA Biosciences, Inc. (2.75B), greater than AnaptysBio, Inc. (1.41B), greater than MeiraGTx Holdings plc (319.63M), greater than Keros Therapeutics, Inc. (1.70B), greater than Homology Medicines, Inc. (-103303255.00), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Avidity Biosciences, Inc. (4.66B), less than Revolution Medicines, Inc. (7.17B), greater than Day One Biopharmaceuticals, Inc. (970.79M), greater than SpringWorks Therapeutics, Inc. (2.57B), less than Cytokinetics, Incorporated (7.18B), greater than DICE Therapeutics, Inc. (2.21B), greater than Edgewise Therapeutics, Inc. (1.75B), less than Karuna Therapeutics, Inc. (12.43B), less than Dyne Therapeutics, Inc. (2.87B), less than Crinetics Pharmaceuticals, Inc. (3.97B), greater than ALX Oncology Holdings Inc. (114.66M), greater than Immatics N.V. (1.01B), greater than BioAtla, Inc. (20.24M), greater than Aerovate Therapeutics, Inc. (24.75M), greater than Travere Therapeutics, Inc. (1.47B), greater than Ventyx Biosciences, Inc. (132.17M), greater than Cogent Biosciences, Inc. (1.08B),

Build a custom stock screener for Celldex Therapeutics, Inc. (CLDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celldex Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celldex Therapeutics, Inc. (CLDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celldex Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.